CME vs IOSP · P/E 22, rev $3.59B vs P/E 18, rev $491.4M
CME Group Inc (CME) versus Innospec Inc (IOSP) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Innospec Inc (IOSP) is a specialty chemicals company listed on NASDAQ.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported IOSP revenue for 2026-06-30 was $491.4M. Net income was $30.8M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
CME currently screens at market cap $91.25B and trailing P/E 21.9. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
Not investment advice. Open the CME and IOSP stock pages for the full models.
Not investment advice.